Novel Insulin Cuts Nocturnal Glucose Plunge

(MedPage Today) -- An investigational long-acting insulin lowered blood sugar with fewer nocturnal hypoglycemic events than conventional insulin glargine (Lantus) in patients with difficult-to-control type 2 diabetes, manufacturer Sanofi announced Tuesday.
Source: MedPage Today Nephrology - Category: Urology & Nephrology Source Type: news